Cargando…

PET/MR in recurrent glioblastoma patients treated with regorafenib: [(18)F]FET and DWI-ADC for response assessment and survival prediction

OBJECTIVE: The use of regorafenib in recurrent glioblastoma patients has been recently approved by the Italian Medicines Agency (AIFA) and added to the National Comprehensive Cancer Network (NCCN) 2020 guidelines as a preferred regimen. Given its complex effects at the molecular level, the most appr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lombardi, Giuseppe, Spimpolo, Alessandro, Berti, Sara, Campi, Cristina, Anglani, Maria Giulia, Simeone, Rossella, Evangelista, Laura, Causin, Francesco, Zorzi, Giovanni, Gorgoni, Giancarlo, Caccese, Mario, Padovan, Marta, Zagonel, Vittorina, Cecchin, Diego
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Institute of Radiology. 2022
Materias:	Full Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722234/ https://www.ncbi.nlm.nih.gov/pubmed/34762492 http://dx.doi.org/10.1259/bjr.20211018

Ejemplares similares

Regorafenib in Recurrent Glioblastoma Patients: A Large and Monocentric Real-Life Study
por: Lombardi, Giuseppe, et al.
Publicado: (2021)

Validation of the Comprehensive Geriatric Assessment as a Predictor of Mortality in Elderly Glioblastoma Patients
por: Lombardi, Giuseppe, et al.
Publicado: (2019)

Diagnostic Value of PET/MR with DWI for Burkitt Lymphoma
por: Giraudo, Chiara, et al.
Publicado: (2021)

Value of DWI- ADC and FUSION T2-DWI in the management of oncological patients
por: Nazar, M, et al.
Publicado: (2015)

The role of radiation therapy and systemic treatments in meningioma: The present and the future
por: Caccese, Mario, et al.
Publicado: (2023)

The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation
por: Tizianel, Irene, et al.
Publicado: (2022)

Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety Study
por: Parrozzani, Raffaele, et al.
Publicado: (2020)

Clinical Management of Diffuse Low-Grade Gliomas
por: Lombardi, Giuseppe, et al.
Publicado: (2020)

Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study
por: Parrozzani, Raffaele, et al.
Publicado: (2020)

DWI/ADC in Differentiation of Benign from Malignant Focal Liver Lesion
por: Jahic, Elma, et al.
Publicado: (2016)

Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives
por: Birzu, Cristina, et al.
Publicado: (2020)

Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO)
por: Padovan, Marta, et al.
Publicado: (2021)

Is DWI/ADC a Useful Tool in the Characterization of Focal Hepatic Lesions Suspected of Malignancy?
por: Testa, Maria Luiza, et al.
Publicado: (2014)

The Influence of Bowel Preparation on ADC Measurements: Comparison between Conventional DWI and DWIBS Sequences
por: Apine, Ilze, et al.
Publicado: (2019)

Does the SUVmax of FDG-PET/CT Correlate with the ADC Values of DWI in Musculoskeletal Malignancies?
por: Ozturk, Mesut, et al.
Publicado: (2021)

Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study
por: Caccese, Mario, et al.
Publicado: (2020)

Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study
por: Olioso, Debora, et al.
Publicado: (2021)

Correlation of Prognostic Factors of Invasive Lobular Carcinoma with ADC Value of DWI and SUVMax of FDG-PET
por: Choi, Bo Bae, et al.
Publicado: (2017)

Improved Visualization of Prostate Cancer Using Multichannel Computed Diffusion Images: Combining ADC and DWI
por: Hammon, Matthias, et al.
Publicado: (2022)

An Overview of Fotemustine in High-Grade Gliomas: From Single Agent to Association with Bevacizumab
por: Lombardi, Giuseppe, et al.
Publicado: (2014)

Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care
por: Ruggiero, Elena, et al.
Publicado: (2022)

Alteration of MR-DWI/ADC before and 24h after induction of chemotherapy in patients with lung cancer
por: Sedlaczek, O, et al.
Publicado: (2014)

Application of first-order feature analysis of DWI-ADC in rare malignant mesenchymal tumours of the maxillofacial region
por: Yu, Baoting, et al.
Publicado: (2021)

Impact of DWI and ADC values in Ovarian-Adnexal Reporting and Data System (O-RADS) MRI score
por: Manganaro, Lucia, et al.
Publicado: (2023)

Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study
por: Caccese, Mario, et al.
Publicado: (2023)

Reproducibility of quantitative ADC, T1, and T2 measurement on the cerebral cortex: Utility of whole brain echo-planar DWI with compressed SENSE (EPICS-DWI): A pilot study
por: Yamashita, Koji, et al.
Publicado: (2023)

Patterns of gray and white matter functional networks involvement in glioblastoma patients: indirect mapping from clinical MRI scans
por: Sansone, Giulio, et al.
Publicado: (2023)

Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI
por: Galldiks, Norbert, et al.
Publicado: (2019)

Glioma Grading Capability: Comparisons among Parameters from Dynamic Contrast-Enhanced MRI and ADC Value on DWI
por: Choi, Hyun Seok, et al.
Publicado: (2013)

Diagnosing a rare thoracic intramedullary spinal dermoid cyst using DWI with ADC mapping: Case report
por: Adams, Jennifer P., et al.
Publicado: (2022)

Urine 2-Hydroxyglutarate in Glioma
por: Lombardi, Giuseppe, et al.
Publicado: (2016)

ADC Histograms from Routine DWI for Longitudinal Studies in Cerebral Small Vessel Disease: A Field Study in CADASIL
por: Gunda, Bence, et al.
Publicado: (2014)

Retrospective Correction of ADC for Gradient Nonlinearity Errors in Multicenter Breast DWI Trials: ACRIN6698 Multiplatform Feasibility Study
por: Malyarenko, Dariya I., et al.
Publicado: (2020)

Safely reducing unnecessary benign breast biopsies by applying non-mass and DWI directional variance filters to ADC thresholding
por: Penn, Alan, et al.
Publicado: (2022)

Considering tumour volume for motion corrected DWI of colorectal liver metastases increases sensitivity of ADC to detect treatment-induced changes
por: Pathak, Ryan, et al.
Publicado: (2019)

Accuracy of ADC derived from DWI for differentiating high-grade from low-grade gliomas: Systematic review and meta-analysis
por: Wang, Qiang-ping, et al.
Publicado: (2020)

Combining ADC values in DWI with rCBF values in arterial spin labeling (ASL) for the diagnosis of mild cognitive impairment (MCI)
por: Sui, Haijing, et al.
Publicado: (2023)

(18)F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature
por: Evangelista, Laura, et al.
Publicado: (2020)

The Utility of Diffusion Weighted Imaging (DWI) Using Apparent Diffusion Coefficient (ADC) Values in Discriminating Between Prostate Cancer and Normal Tissue
por: Łuczyńska, Elżbieta, et al.
Publicado: (2014)

Grading Gliomas Capability: Comparison between Visual Assessment and Apparent Diffusion Coefficient (ADC) Value Measurement on Diffusion-Weighted Imaging (DWI)
por: Phuttharak, Warinthorn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bcgtvmf8cl257om4dcfnhffb0k